Search research articles
Contact Us
Filters
Showing results (221-230 of 226) with videos related to
Page
of 23
Sort By:
You have reached the last page of results.
This site can display upto 226 results.
Journal of Oncology Practice
|
October 17, 2013
The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations
Andrea M Denicoff, Worta McCaskill-Stevens, Stephen S Grubbs, et al.
The Oncologist
|
December 20, 2019
Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204)
A Bapsi Chakravarthy, Fengmin Zhao, Neal J Meropol, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 25, 2018
Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group
Kaitlyn K H Goey, Halfdan Sørbye, Bengt Glimelius, et al.
The Lancet. Oncology
|
October 1, 2011
Delivering affordable cancer care in high-income countries
Richard Sullivan, Jeffrey Peppercorn, Karol Sikora, et al.
The Lancet. Oncology
|
December 7, 2017
Future cancer research priorities in the USA: a Lancet Oncology Commission
Elizabeth M Jaffee, Chi Van Dang, David B Agus, et al.
Mayo Clinic Proceedings
|
July 28, 2015
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs
Ayalew Tefferi, Hagop Kantarjian, S Vincent Rajkumar, et al.
Page
of 23
Search research articles
Search
Showing results (221-230 of 226) with videos related to
Sort By:
Page
of 23
You have reached the last page of results.
This site can display upto 226 results.
Journal of Oncology Practice
|
October 17, 2013
The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations
Andrea M Denicoff, Worta McCaskill-Stevens, Stephen S Grubbs, et al.
The Oncologist
|
December 20, 2019
Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204)
A Bapsi Chakravarthy, Fengmin Zhao, Neal J Meropol, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 25, 2018
Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group
Kaitlyn K H Goey, Halfdan Sørbye, Bengt Glimelius, et al.
The Lancet. Oncology
|
October 1, 2011
Delivering affordable cancer care in high-income countries
Richard Sullivan, Jeffrey Peppercorn, Karol Sikora, et al.
The Lancet. Oncology
|
December 7, 2017
Future cancer research priorities in the USA: a Lancet Oncology Commission
Elizabeth M Jaffee, Chi Van Dang, David B Agus, et al.
Mayo Clinic Proceedings
|
July 28, 2015
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs
Ayalew Tefferi, Hagop Kantarjian, S Vincent Rajkumar, et al.
Page
of 23